foxo4-dri senolytic peptide mechanism Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI (Proxofim) 10mg*10 vials -
FOXO4 DRI (Proxofim) 10mg*10 vials Nexus peptides Your Gateway To High Quality Peptides FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



